Page last updated: 2024-10-29

staurosporine aglycone and Ewing Sarcoma

staurosporine aglycone has been researched along with Ewing Sarcoma in 2 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Research Excerpts

ExcerptRelevanceReference
"Four Ewing's sarcomas, one Wilm's tumor, and one melanoma were examined."1.28Functional receptors for nerve growth factor on Ewing's sarcoma and Wilm's tumor cells. ( Greene, LA; Pellicer, A; Thomson, TM, 1989)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heinen, TE1
Dos Santos, RP1
da Rocha, A1
Dos Santos, MP1
Lopez, PL1
Silva Filho, MA1
Souza, BK1
Rivero, LF1
Becker, RG1
Gregianin, LJ1
Brunetto, AL1
Brunetto, AT1
de Farias, CB1
Roesler, R1
Thomson, TM1
Pellicer, A1
Greene, LA1

Other Studies

2 other studies available for staurosporine aglycone and Ewing Sarcoma

ArticleYear
Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.
    Oncotarget, 2016, Jun-07, Volume: 7, Issue:23

    Topics: Antineoplastic Agents; Azepines; Benzamides; Brain-Derived Neurotrophic Factor; Carbazoles; Cell Lin

2016
Functional receptors for nerve growth factor on Ewing's sarcoma and Wilm's tumor cells.
    Journal of cellular physiology, 1989, Volume: 141, Issue:1

    Topics: Carbazoles; Deoxyadenosines; Gene Amplification; Gene Expression Regulation; Humans; In Vitro Techni

1989